MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字H20253371

February 11, 2025

Drug Information

盐酸奥洛他定滴眼液

眼用制剂

0.2%(2.5ml:5mg,按C₂₁H₂₃NO₃计)

化学药品

February 11, 2025

Company Information

Applicant Company

深圳市光明新区凤凰街道汇通路7号万和科技大厦

Manufacturing Company

深圳市光明新区汇通路7号万和科技大厦B、C、D 栋

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.